![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LabCorp’s High-Throughput COVID-19 Test Gets FDA Authorization
LabCorp’s High-Throughput COVID-19 Test Gets FDA Authorization
![](https://www.fdanews.com/ext/resources/test/Device_Images3/labcorp-logo.gif?t=1433971929&width=430)
LabCorp has received an Emergency Use Authorization (EUA) from the FDA for a high-throughput COVID-19 molecular test that doesn’t require reagents for extracting RNA from the samples.
The test instead uses a heat-based extraction process that is as sensitive at the conventional reagent-based extraction methods.
The innovative extraction method improves testing efficiency and reduces reliance on testing supplies, LabCorp said.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct